3848 studies found for:    "Slow Virus Diseases"
Show Display Options
Rank Status Study
1 Recruiting Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The Treatment of Acute HIV-1 Infected Adults
Condition: Acute HIV Infection
Interventions: Drug: cART(TDF/AZT+3TC+LPV/r);   Procedure: CTL infusion
2 Terminated A Study to Assess the Long-term Efficacy (24 Weeks) of MPC-4326 in Combination With a 2-3 Drug OBR Relative to the Efficacy of a 3-4 Drug ARV Regimen in Treatment Experienced HIV-1 Infected Subjects Who Are Failing Current Antiretroviral Therapy
Condition: HIV Infections
Interventions: Drug: MPC-4326 plus a 2-3 drug optimized background regimen (OBR);   Drug: 3-4 commercially available antiretroviral drugs
3 Completed GSK1349572 Relative Bioavailability Study
Condition: HIV Infections
Interventions: Drug: GSK1349572 formulation AP;   Drug: GSK1349572 formulation AW;   Drug: GSK1349572 formulation AX
4 Completed Comparison of Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS
Conditions: Pneumonia, Pneumocystis Carinii;   HIV Infections
Interventions: Drug: Trimetrexate glucuronate;   Drug: Pentamidine isethionate;   Drug: Sulfamethoxazole-Trimethoprim;   Drug: Leucovorin calcium
5 Completed Assessing HIV-Related Oral Mucosal Disease and Using Saliva to Measure Viral Load
Condition: HIV Infections
Intervention:
6 Completed A Study of Nystatin in HIV-Infected Patients
Condition: HIV Infections
Interventions: Drug: Nystatin;   Drug: Didanosine
7 Active, not recruiting Epidemiology and Pathogenesis of HIV-Associated Pulmonary Hypertension
Conditions: HIV Infection;   Pulmonary Hypertension;   Endothelial Function;   HIV Infections
Intervention:
8 Completed Safety and Pharmacokinetic Trial in Healthy HIV-Negative Women to Assess the Delivery of Dapivirine From a Vaginal Ring
Condition: HIV Infections
Interventions: Drug: dapivirine;   Drug: placebo
9 Completed Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics
Condition: HIV Infections
Intervention:
10 Completed Clinical Trial to Evaluate the Immunogenicity and Safety of an Adjuvanted A(H1N1)v Influenza Vaccine and a Non-adjuvanted A(H1N1)v Influenza Vaccine in HIV-infected Patients (ANRS 151 Hifluvac)
Condition: HIV Infections
Interventions: Biological: adjuvanted A(H1N1)v influenza vaccine;   Biological: non-adjuvanted A(H1N1)v influenza vaccine
11 Completed A Study of Patients Who Develop HIV Infection After Enrolling in HIV Vaccine Trials or HIV Vaccine Preparedness Trials
Condition: HIV Infections
Intervention: Other: Observation
12 Completed A Pilot Study of Fluconazole Plus Flucytosine for the Treatment of AIDS Patients With Acute Cryptococcal Meningitis.
Conditions: Meningitis, Cryptococcal;   HIV Infections
Interventions: Drug: Flucytosine;   Drug: Fluconazole
13 Completed A Study to Compare Two Anti-HIV Combination Therapies Each Containing Saquinavir in HIV-Positive Children
Condition: HIV Infections
Interventions: Drug: Ritonavir;   Drug: Nelfinavir mesylate;   Drug: Saquinavir
14 Completed The Safety and Effectiveness of 1592U89 Plus 141W94 Plus DMP 266 in Patients With HIV Who Developed a Resistance to Protease Inhibitors
Condition: HIV Infections
Interventions: Drug: Abacavir sulfate;   Drug: Amprenavir;   Drug: Efavirenz
15 Terminated Can Presumptive Anthelminthic Treatment Delay the Progression of HIV in ART-naïve Patients in Rural Africa?
Conditions: HIV Infections;   Helminthiasis
Intervention: Drug: Praziquantel, Ivermectin, Albendazole
16 Completed A Study of MKC-442 in HIV-Positive Patients
Condition: HIV Infections
Intervention: Drug: Emivirine
17 Completed The Adult Antiretroviral Treatment and Resistance Study (Tshepo)
Conditions: AIDS;   HIV Infection
Interventions: Drug: (A) zidovudine, lamivudine and nevirapine;   Drug: (B) zidovudine, lamivudine and efavirenz;   Drug: (C) zidovudine, didanosine, and nevirapine;   Drug: (D) zidovudine, didanosine, and efavirenz;   Drug: (E) stavudine, lamivudine, and nevirapine;   Drug: (F) stavudine, lamivudine and efavirenz;   Procedure: Adherence Strategy Standard of Care (SOC);   Procedure: Adherence Strategy Community-Based DOT
18 Completed Study to Evaluate HIV Viremia and Persistence in Acutely HIV-Infected ARV Naïve Patients Treated With Darunavir/Ritonavir and Etravirine
Conditions: Acute HIV Infection;   HIV Infections
Intervention: Drug: Darunavir/Ritonavir and Etravirine
19 Completed A Study of Anti-HIV Monoclonal Antibody KD-247
Condition: HIV Infections
Interventions: Drug: KD-247;   Drug: Physiological saline
20 Completed A Phase I Clinical Trial To Evaluate the Toxicity, Antiviral and Immunomodulatory Effects of a Range of Doses of Ampligen in HIV-Infected Subjects
Condition: HIV Infections
Intervention: Drug: Ampligen

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years